NVRO News and Press, Nevro Corp. From 10/04/23

Nevro to Report Third Quarter 2023 Financial Results PR Newswire Company to Host Conference Call on Wednesday, November 1, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , Oct. 4, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a glo...

2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...

New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy PR Newswire Publications Show Reductions in Hospital Resource Utilization Associated with 10 kHz Therapy Spinal Cord Stimulation for the Treatment of Painful Diabeti...

2023-09-01 15:54:03 ET Summary Nevro Corp. shares have significantly underperformed, selling 57% lower than in 2021. The company's top-line momentum continues, but it faces economic challenges and lacks value creation for shareholders. As a positive, NVRO's Q2 FY'23 showed sig...

TORONTO, ON / ACCESSWIRE / August 30, 2023 / EnviroGold Global Limited (CSE:NVRO)(OTCQB:ESGLF)(FSE:YGK) ("EnviroGold Global" or the "Company"), a clean technology company accelerating the world's transition to a circular-resource economy, today announced that it will be presenting at the Planet ...

TORONTO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited ( CSE:NVRO | OTCQB:ESGLF | FSE:YGK ) (“EnviroGold Global”), a clean technology company accelerating the world’s transition to a circular-resource economy and Luca Mining Corp. (“ Luca ...

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy PR Newswire Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Qualit...

2023-08-02 15:40:29 ET Shares of Nevro (NYSE: NVRO) were down more than 19% as of 3:30 p.m. ET on Wednesday after the company announced second-quarter earnings. The healthcare stock is down more than 49% so far this year. Nevro is a medical device company that focuses on the...

2023-08-02 10:17:25 ET Gainers: TRxADE HEALTH ( MEDS ) +60% . Armata Pharmaceuticals ( ARMP ) +17% . Teva Pharmaceutical Industries ( TEVA ) +13% . CareDx ( CDNA ) +9% . Mallinckrodt ( MNK ) +9% . Losers: Adamis Pharmaceut...

2023-08-01 20:11:02 ET Nevro Corp. (NVRO) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group LLC Kevin Thornal - President and CEO Rod MacLeod - Chief Financial Officer Conference Call Participan...